Genetic variation in PCSK9 has an enormous impact on the LDL-C levels and has been described either in loss-of-function (LOF) mutation that cause hypocholesterolaemia or GOF mutation, which is associated with FH [98]. Here, PCSK9 is linked to familial hyperaldosteronism.